14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.95 $2.61 Monday, 22nd Apr 2024 CHRS stock ended at $2.18. This is 5.31% more than the trading day before Friday, 19th Apr 2024. During the day the stock fluctuated 7.35% from a day low at $2.04 to a day high of $2.19.
90 days $1.93 $2.87
52 weeks $1.44 $8.33

Historical Coherus BioSciences prices

Date Open High Low Close Volume
Sep 20, 2021 $17.05 $17.70 $16.96 $17.39 1 104 404
Sep 17, 2021 $16.25 $17.79 $16.16 $17.56 3 600 429
Sep 16, 2021 $15.68 $16.04 $15.30 $16.03 673 204
Sep 15, 2021 $16.16 $16.16 $15.72 $15.79 482 164
Sep 14, 2021 $16.22 $16.30 $15.83 $16.08 761 539
Sep 13, 2021 $15.38 $16.24 $14.98 $16.17 828 888
Sep 10, 2021 $15.79 $15.79 $15.35 $15.39 399 621
Sep 09, 2021 $15.70 $15.96 $15.41 $15.77 471 135
Sep 08, 2021 $15.15 $15.64 $15.05 $15.64 534 011
Sep 07, 2021 $15.54 $15.54 $14.66 $15.08 891 307
Sep 03, 2021 $16.11 $16.11 $15.55 $15.70 440 504
Sep 02, 2021 $16.08 $16.28 $16.01 $16.23 470 025
Sep 01, 2021 $15.96 $16.24 $15.80 $16.12 412 227
Aug 31, 2021 $15.80 $16.01 $15.77 $15.98 499 909
Aug 30, 2021 $15.84 $16.04 $15.78 $15.84 464 892
Aug 27, 2021 $15.96 $16.15 $15.71 $15.75 928 434
Aug 26, 2021 $15.37 $16.00 $15.37 $15.82 769 254
Aug 25, 2021 $15.37 $15.59 $15.05 $15.45 461 485
Aug 24, 2021 $15.27 $15.43 $14.99 $15.37 471 743
Aug 23, 2021 $15.14 $15.60 $14.90 $15.37 778 283
Aug 20, 2021 $14.23 $15.29 $14.20 $15.00 810 141
Aug 19, 2021 $14.32 $15.57 $14.32 $14.53 2 380 276
Aug 18, 2021 $14.68 $14.68 $14.13 $14.14 685 217
Aug 17, 2021 $14.00 $14.68 $13.81 $14.67 802 066
Aug 16, 2021 $13.81 $14.32 $13.70 $14.04 809 811
Click to get the best stock tips daily for free!

About Coherus BioSciences

Coherus BioSciences Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. The company also develops Toripalimab, a novel anti-PD-1 antibody for second-line treatment of melanoma ... CHRS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT